-
ABPI Website
- Partnerships
Building better partnerships between industry & the NHS, & across the life sciences sector
ABPI Patient Advisory Council
Council members provide the Association’s Board and its senior team with meaningful insights into the patient experience, to inform strategy, policy priorities and work.
NHS-Industry Partnership Case Studies Repository
Explore examples of how collaboration and partnership can support delivery of NHS priorities and enable the ‘triple win’ - of improved patient outcomes, more efficient use of NHS resources and evidence of impact for industry – as well as replication and scaling across the NHS.
NHS engagement
Accelerating transformation: How to develop effective NHS-industry partnerships
The NHS Confederation and the ABPI have created new guidance on how to create effective NHS-industry partnerships. It was created with the expertise of more than 30 NHS and industry leaders.
Working with patients and patient organisations - 2022 sourcebook for industry
The ABPI has produced this sourcebook to support pharmaceutical companies, patients and patient organisations work together successfully, with relationships that are in the interests of patients and meet the standards set out in the 2021 ABPI Code of Practice.
Patient involvement
The ABPI want to lead the way in ensuring patient engagement is integral to our work. To support this ambition, we work with patient organisations and ABPI members to identify the priorities we should focus on.
Patient & public involvement
ABPI Patient Engagement Strategy
Our strategy sets out how the ABPI will deliver our commitments and make sure that patient engagement is consistently at the heart of our work.
Patient and public involvement in research
Involving the public and patients as equal partners in the discovery and development of medicines is vital. The ABPI works with patient organisations and our members to improve how this is done.
Academic collaboration
Academic collaboration
A quarter of a million people are employed in the UK’s life science sector today. We need a continuous supply of specialists to stay competitive, meet the demands of an evolving, technology-based world and pioneer the next wave of medicines and vaccines.
Links between industry & academia
The UK is recognised worldwide as a leader in medical research and innovation, and the foundations for collaborations between industry and academia in the UK are exceptionally strong.